|
Healthcare professional reported a patient was injected with skinvive¿ by juvéderm® into the right and left malar/zygomatic areas.Patient also concomitantly received nuera and back and cheek laser hair removal.The next day, patient reported presenting with left cheek erythema and good capillary refill.Swelling and mild tenderness also reported.Patient showed slight improvement of erythema each day.Patient was treating area with 2.5% hydrocortisone ointment and biopelle 40 serum multiple times a day.It was noted as of three days after onset the swelling remained and capillary refill was 1-2 seconds.The lower edge of the cheek area was a little darker in color and the redness of the upper edge had resolved by 75%.Patient was prescribed a medrol dose pack, starting with 4 a day then tapering.Patient also given revivisomes, biopelle 40's 2.5% hydrocortisone, doxycycline 100mg.Patient also reportedly rook bacitracin ointment.Patient travelled overseas but returned two weeks later.It was noted the skin had cleared up, good capillary refill and very little erythema.There was a small amount of hyperpigmentation in the lower perinasal area remaining.Patient reportedly had pus coming from the area while overseas.
|
|
Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The event is a physiological complication and analysis of the device generally does not assist abbvie in determining a probable cause for this event.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.A review of the
this is a known potential adverse event addressed in the product labeling.
|